Dutch startup Salvia BioElectronics this week said it received FDA breakthrough device designation for its implantable neurostimulation system to treat chronic migraine. Salvia’s system is based on a novel device concept using thin and conforming bioelectronic foils that it says uniquely adapt to the anatomy of the head. “The FDA breakthrough device designation of our […]